Cardiovascular risk factors in patients with chronic kidney disease

Area of Science:

• Nephrology
• Cardiology
• Internal Medicine

Background:

• Patients with chronic kidney disease (CKD) exhibit a significantly higher burden of cardiovascular disease (CVD).
• CVD risk escalates with declining kidney function, influenced by traditional risk factors in mild-to-moderate CKD.
• Severe CKD involves novel risk factors such as inflammation, oxidative stress, vascular calcification, prothrombotic state, and anemia, contributing additional CVD risk.

Purpose of the Study:

• To review cardiovascular risk factors in patients with reduced estimated glomerular filtration rate (eGFR).
• To discuss therapeutic strategies for mitigating CVD risk in the unique context of kidney disease.
• To emphasize the need for evaluating therapeutic paradigms in randomized trials for CKD populations.

Main Methods:

• Literature review focusing on cardiovascular risk in reduced eGFR.
• Analysis of traditional and non-traditional CVD risk factors in CKD.
• Discussion of therapeutic approaches tailored to CKD patients' unique atherosclerotic phenotype.

Main Results:

• Traditional risk factors (age, diabetes, hypertension, dyslipidemia) are key in mild-to-moderate CKD.
• Non-traditional factors (inflammation, oxidative stress, vascular calcification, prothrombotic state, anemia) are significant in severe CKD.
• CKD patients possess a distinct atherosclerotic phenotype requiring specialized treatment models.

Conclusions:

• Cardiovascular risk in CKD is multifactorial, evolving with disease severity.
• Current CVD models may not fully apply to CKD patients; novel therapeutic strategies are essential.
• Randomized trials are crucial for validating new treatments for CKD patients with cardiovascular risk factors.